Actinium Pharmaceuticals Inc (ATNM)

[wolfgang-germany]

from BioNap Research:

Actinium Pharmaceuticals (ATNM) - ATNM closed a $16.125 million public offering this week. Terms were not so good. The company sold 21.5 million shares at only 75¢. What's worse, they also included 18.275 million five year warrants at $1.05 per share. This was a very painfully dilutive offering by ATNM and those warrants are going to keep the stock under $1.00 at least until ASH in December. Hopefully, at ASH, the company can present some positive data on Actimab-A that gets the stock out of the current downtrend. I really like Phase 3 candidate Iomab-B, but I'm a bit baffled by this highly dilutive offering ATNM entered into a $75 million ATM just last month. They could have easily raised $16 million via the ATM at higher levels (the stock was $1.00-1.20 for most of July) and eliminated the need for 18.275 million ugly warrants.